Home Page ::: Current Neuropharmacology

ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)

Volume 13, 6 Issues, 2015

Download PDF Flyer

Current Neuropharmacology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 113th of 252 in


  • 75th of 254 in

    Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online


T.E. Salt

University College London
Institute of Ophthalmology
London EC1V 9EL

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.049
5 - Year: 3.799

New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].


"By providing succinct reviews of recent advances, Current Neuropharmacology will greatly facilitate readers' comprehension of the big picture."

Solomon H. Snyder
Johns Hopkins Univ., USA

Forthcoming Special Issue(s)

The faces of Mania: the legacy of Athanasios Koukopoulos

Guest Editor(s): Sani G, Kotzalidis GD, Girardi P
Tentative Publication Date: April, 2016
Submit Abstract via Email Download Description
Published Special Issue(s)

Role of Antioxidants treatments on Oxidative Stress and Calcium Entry in Neurological Disease: Focus on TRP Channels

Guest Editor(s): Mustafa Nazıroğlu
Download Description
Authors' Comments
I am very satisfied of my collaboration with the journal Current Neuropharmacology and Bentham Science Publishers. I received constant support from the journal manager, when requested, and the production was rapid and efficient. Plus, the quality of the galley proofs was excellent.
With regard to my publication (and the whole special issue), I think it can be of interest for the academia and industry, as it describes a new method that can be used in behavioral neuropharmacology and drug screening. Therefore, the reviews reported in the special issue may attract interest from the researchers working in the drug discovery and drug evaluation fields.

Nicola Simola
Has contributed: Rat Ultrasonic Vocalizations and Behavioral Neuropharmacology the Screening of Drugs to the Study of Disease

Current Neuropharmacology


Volume 13


Number 2

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

Lurdes Tse, Alasdair M. Barr, Vanessa Scarapicchia and Fidel Vila-Rodriguez

View Abstract Download Free


The Neuropharmacology of Cluster Headache and Trigeminal Autonomic Cephalalgia

Alfredo Costa, Fabio Antonaci, Matteo Cotta Ramusino and Giuseppe Nappi

View Abstract Purchase Online


Neuropharmacological Actions of Metformin in Stroke

Jia Jia, Jian Cheng, Jingshu Ni and Xuechu Zhen

View Abstract Purchase Online


Cognitive Dysfunction in Major Depressive Disorder: a Novel Therapeutic Target?

Beatrice Bortolato, Andre F. Carvalho and Roger S. McIntyre

View Abstract


Beyond monoamines --- Novel Targets for Treatment-Resistant

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho

View Abstract


Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira

View Abstract


Omega 3 Fatty Acids: Novel Neurotherapeutic Targetsfor Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

View Abstract


Pharmacological Approaches for Treatment-Resistant Bipolar Disorder

Shi Hui Poon, Kang Sim and Ross J. Baldessarini

View Abstract


The Involvement of TNF-α in Cognitive Dysfunction associated with Major Depressive Disorder: an Opportunity for Domain Specific Treatments

Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre

View Abstract



Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science